In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GSK may buy minority stake in African pharmaco Aspen

Executive Summary

Several secondary sources have reported that GlaxoSmithKline is in discussions to acquire 10-25% of public South African drug company Aspen Pharmacare. Analysts say that instead of spending cash, GSK would trade some of its assets for the equity stake.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity

Related Companies

UsernamePublicRestriction

Register